Authors

• Patrick A. Flume (ORCID: https://orcid.org/0000-0002-1560-6879)
• Kevin L. Winthrop (ORCID: https://orcid.org/0000-0002-3892-6947)
• Kozo Morimoto (ORCID: https://orcid.org/0000-0002-8239-9275)
• Dario Andrisani (ORCID: https://orcid.org/0000-0003-3860-0063)
• Korkut Avsar (ORCID: https://orcid.org/0000-0002-9483-7412)
• Chau‐Chyun Sheu (ORCID: https://orcid.org/0000-0002-7979-3749)
• Marie-Laure Névoret (ORCID: https://orcid.org/0000-0002-4541-4026)
• Charles L. Daley (ORCID: https://orcid.org/0000-0003-3324-926X)
• James Duncan Chalmers (ORCID: https://orcid.org/0000-0001-5514-7868)
• David E. Griffith (ORCID: https://orcid.org/0000-0003-1458-3385)
• Luigi Ruffo Codecasa (ORCID: https://orcid.org/0000-0001-6825-2050)
• Kevin C. Mange
• Naoki Hasegawa
• Dayton W. Yuen
• Mariam Hassan

Institutions

• Kaohsiung Medical University (TW)
• Medical University of South Carolina (US)
• Keio University (JP)
• Ninewells Hospital (GB)
• Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
• National Jewish Health (US)
• Azienda Ospedaliero-Universitaria di Modena (IT)
• Insmed (United States) (US)
• German Center for Lung Research (DE)
• Fukujuji Hospital (JP)
• University of Portland (US)
• University of Colorado Denver (US)

Publication Details

Journal

Pulmonary Therapy

Published

2025-04-08

DOI

https://doi.org/10.1007/s41030-025-00293-3

Citations

1

Primary Topic

Lung Cancer Diagnosis and Treatment

Type

article

Field-Weighted Citation Impact

1.52

Funders

• Bill and Melinda Gates Foundation
• Pfizer
• AstraZeneca
• Gilead Sciences
• Patient-Centered Outcomes Research Institute
• COPD Foundation
• MannKind Corporation
• Insmed
• Grifols
• National Institutes of Health
• Genentech
• Janssen Pharmaceuticals